Towards clinical application of mesenchymal stem cells for treatment of neurological diseases of the central nervous system

Author(s): Laroni A, Novi G, Kerlero de Rosbo N, Uccelli A


The diagnosis of a neurological disease of the central nervous system (CNS) is often associated with the anticipation of an irreversible and untreatable disability. This is the case also of multiple sclerosis (MS) where approved treatments effectively modulate the autoimmune attack to myelin antigens, but poorly affect neurodegeneration and do not promote tissue repair. Thus, stem cell-based therapies are increasingly being considered a possible strategy for diseases of the CNS. Mesenchymal stem cells (MSC), the safety of which has been demonstrated in the last 20 years through clinical trials and case studies, are of particular interest in view not only of their neuroprotective, but also of their immunomodulatory properties. Here, we review the therapeutic features of MSC that make them relevant in the treatment of CNS illnesses and discuss the pioneer clinical experience with MSC-based therapy in neurological diseases.

Similar Articles

Stem cell transplantation in multiple sclerosis: current status and future prospects

Author(s): Martino G, Franklin RJ, Baron Van Evercooren A, Kerr DA; Stem Cells in Multiple Sclerosis (STEMS) Consensus Group

Progress and prospects: stem cells and neurological diseases

Author(s): Gögel S, Gubernator M, Minger SL

Isolation of amniotic stem cell lines with potential for therapy

Author(s): De Coppi P1, Bartsch G Jr, Siddiqui MM, Xu T, Santos CC, et al.

Mesenchymal and haematopoietic stem cells form a unique bone marrow niche

Author(s): Méndez-Ferrer S, Michurina TV, Ferraro F, Mazloom AR, Macarthur BD, et al.

The potential of mesenchymal stromal cells as a novel cellular therapy for multiple sclerosis

Author(s): Auletta JJ, Bartholomew AM, Maziarz RT, Deans RJ, Miller RH, et al.

Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals

Author(s): Djouad F, Plence P, Bony C, Tropel P, Apparailly F, et al.

Allogeneic mesenchymal stem cells transplantation in treatment of multiple sclerosis

Author(s): Liang J, Zhang H, Hua B, Wang H, Wang J, et al.

Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis

Author(s): Riordan NH, Ichim TE, Min WP, Wang H, Solano F, et al.

Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy

Author(s): Zappia E, Casazza S, Pedemonte E, Benvenuto F, Bonanni I, et al.

Reciprocal Th1 and Th17 regulation by mesenchymal stem cells: Implication for multiple sclerosis

Author(s): Darlington PJ, Boivin MN, Renoux C, François M, Galipeau J, et al.